会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明申请
    • Pyrazole derivative
    • 吡唑衍生物
    • US20010011090A1
    • 2001-08-02
    • US09773736
    • 2001-02-02
    • Hirokazu KubotaYasuhiro YonetokuKeizo SugasawaMasashi FunatsuSouichirou KawazoeAkira ToyoshimaYoshinori OkamotoJun IshikawaMakoto Takeuchi
    • A61K031/535A61K031/497A61K031/445A01N043/40A61K031/415A01N043/56
    • C07D231/12C07D231/14C07D233/56C07D249/08C07D401/12C07D403/12C07D409/04C07D409/12C07D409/14C07D417/04C07D417/12C07D417/14
    • Drugs, in particular, pyrazole derivatives represented by the following general formula (I) which have a calcium release-dependent calcium channel inhibitory effect and medicinal compositions, in particular, calcium release-dependent calcium channel inhibitors containing the above compounds as the active ingredient, 1 (in the formula, each symbol has the following meaning: B: phenylene, a nitrogen-containing, divalent, saturated ring group, or a monocyclic, divalent heteroaromatic ring group which may be substituted with Alk, X: nullNR1nullCR2R3null, nullCR2R3nullNR1null, nullNR1SO2null, nullSO2nullNR1null or nullCR4nullCR5null, and A: benzene ring which may have one or more substituents; mono-, di- or tricyclic fused heteroaryl which may have one or more substituents; cycloalkyl which may have one or more substituents; a nitrogen-containing, saturated ring group which may have one or more substituents; lower alkenyl which may have one or more substituents; lower alkynyl which may have one or more substituents; or Alk which may have one or more substituents).
    • 药物,特别是具有钙释放依赖性钙通道抑制作用的药物组合物,特别是含有上述化合物作为活性成分的钙释放依赖性钙通道抑制剂的下述通式(I)表示的吡唑衍生物, (在该式中,每个符号具有以下含义:B:亚苯基,含氮,二价饱和环基或可被Alk,X:-NR1-CR2R3-取代的单环,二价杂芳族环基团, -CR2R3-NR1-,-NR1SO2-,-SO2-NR1-或-CR4 = CR5-,和A:可具有一个或多个取代基的苯环;可具有一个或多个取代基的单 - ,二 - 或三环稠合杂芳基 取代基;可具有一个或多个取代基的环烷基;可具有一个或多个取代基的含氮饱和环基;可具有一个或多个取代基的低级烯基;可具有一个或多个取代基的低级炔基;或Alk, 可能 具有一个或多个取代基)。
    • 45. 发明申请
    • Fungicidal composition based on at least one pyridylmethylbenzamide derivatives and at least on dithiocarbamate derivative
    • 基于至少一种吡啶基甲基苯甲酰胺衍生物和至少二硫代氨基甲酸酯衍生物的杀真菌组合物
    • US20040266829A1
    • 2004-12-30
    • US10493591
    • 2004-04-23
    • Richard MercerThomas Wegmann
    • A01N055/00A01N043/40
    • A01N43/40A01N2300/00
    • 1) Fungicidal compositions comprising: a) at least one pyridylmethylbenzamide derivative of formula (I), in which the various radicals are as defined in the description, and b) at least one compound (II) chosen from dithiocarbamates, preferably fungicidal dithiocarbamates, and, still more preferably from the following active agents: ferbam, mancopper, mancozeb, maneb, metiram, nabam, nickel bis(dimethyldithio-carbamate), propineb, zineb and mixtures thereof.; and their agriculturally acceptable isomers and addition salts with an acid. 2) Method for the curative or preventive control of phytopathogenic fungi of crops using an effective and non-phytotoxic quantity of one of these fungicidal compositions.
    • 1)杀真菌组合物,其包含:a)至少一种式(I)的吡啶基甲基苯甲酰胺衍生物,其中各种基团如说明书中所定义,和b)至少一种选自二硫代氨基甲酸盐,优选杀真菌二硫代氨基甲酸盐的化合物(II)和 ,还更优选来自以下活性剂:ferbam,mancopper,代森锰锌,芒硝,metiram,纳巴姆,双(二甲基二硫代氨基甲酸镍)镍,丙炔,吖嗪及其混合物。 及其农业上可接受的异构体和与酸的加成盐。 2)使用有效和非植物毒性量的这些杀真菌组合物之一治疗或预防控制作物的植物病原真菌的方法。
    • 47. 发明申请
    • Method for improving plant growth
    • 改善植物生长的方法
    • US20040224847A1
    • 2004-11-11
    • US10859929
    • 2004-06-03
    • Robert SennDieter HoferThomas ThiemeLarry Zang
    • A01N043/40A01N043/08
    • A01N51/00A01N43/40A01N47/40
    • Disclosed is a method of improving the growth of plants wherein at least one compound of formula (I) 1 wherein A is 2-chloropyrid-5-yl, 2-methylpyrid-5-yl, 1-oxido-3-pyridinio, 2-chloro-1-oxido-5-pyridinio, 2,3-dichloro-1-oxido-5-pyridinio, tetrahydrofuran-3-yl, 5-methyl-tetrahydrofuran-3-yl or 2-chlorothiazol-5-yl group, R is hydrogen, C1-C6alkyl, phenyl-C1-C4alkyl, C3-C6cycloalkyl, C2-C6alkenyl or C2-C6alkynyl; Y is nullN(R)(R2) or SR2; R1 and R2 are independently of each other C1-C4-alkyl, C1-C4-alkenyl, C1-C4-alkinyl nullC(nullO)nullCH3 or benzyl; or together form a group nullCH2nullCH2null, nullCH2nullCH2nullCH2null, nullCH2nullOnullCH2null, nullCH2nullSnullCH2null, nullCH2nullNHnullCH2null or nullCH2nullN(CH3)nullCH2null; and X is NnullNO2 or NnullCN or CHnullNO2; or, where appropriate, a tautomer thereof, in each case in free from or in salt form; is applied to the plant or the locus thereof.
    • 公开了一种改善植物生长的方法,其中至少一种式(I)化合物,其中A是2-氯吡啶-5-基,2-甲基吡啶-5-基,1-氧化-3-吡啶并吡啶,2-氯 -1-氧化-5-吡啶鎓,2,3-二氯-1-氧化-5-吡啶并,四氢呋喃-3-基,5-甲基 - 四氢呋喃-3-基或2-氯噻唑-5-基,R为 氢,C 1 -C 6烷基,苯基-C 1 -C 4烷基,C 3 -C 6环烷基,C 2 -C 6烯基或C 2 -C 6炔基; Y是-N(R)(R2)或SR2; R 1和R 2彼此独立地为C 1 -C 4 - 烷基,C 1 -C 4 - 烯基,C 1 -C 4 - 炔基-C(= O)-CH 3或苄基; 或一起形成基团-CH 2 -CH 2 - , - CH 2 -CH 2 - , - CH 2 -O-CH 2 - , - CH 2 -S-CH 2 - , - CH 2 -NH-CH 2 - 或-CH 2 -N(CH 3) -CH 2 - ; X为N-NO 2或N-CN或CH-NO 2; 或在适当情况下,其互变异构体在每种情况下不含或以盐形式存在; 施用于植物或其基因座。
    • 48. 发明申请
    • System and method for monitoring efficacy of web-based online behavioral clinical study
    • 基于网络的在线行为临床研究监测功效的系统和方法
    • US20040220833A1
    • 2004-11-04
    • US10823114
    • 2004-04-13
    • Joseph A. Matthias
    • A61K031/44A01N043/40G06F017/60G09B019/18
    • G09B23/28G06Q30/02G06Q50/22G09B7/00G16H10/20
    • A system and method which evaluates the efficacy of tailored online health related behavioral materials provided to a human subject. More particularly, a method of evaluating the efficacy of online behavioral material in a clinical study including enrolling a plurality of customers, performing a computerized initial, randomly segregating the plurality of customers into a first group which accesses tailored behavioral material online and a second group which accesses non-tailored behavioral material online, providing the first group with tailored behavioral material, providing the second group with non-tailored behavioral material, providing the first group and the second group with a computerized first and second series of questions, analyzing the responses of the first group and the second group to the first and second series of questions according to predetermined factors, and evaluating the efficacy of the behavioral material.
    • 评估提供给人类受试者的定制在线健康相关行为材料的功效的系统和方法。 更具体地,涉及一种在临床研究中评估在线行为材料的功效的方法,包括登记多个顾客,执行计算机化的初始,将多个顾客随机分离成在线访问定制行为材料的第一组,以及第二组, 在线访问非定制的行为材料,为第一组提供量身定制的行为材料,为第二组提供非定制的行为材料,为第一组和第二组提供计算机化的第一和第二系列问题,分析 第一组和第二组根据预定因素对第一和第二系列问题进行评估,并评估行为材料的功效。